Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Novel Antipsychotic Use in Schizophrenia PDF $40.00
$40.00
× Placeholder The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF $40.00
$40.00
× Placeholder Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study PDF $40.00
$40.00
× Placeholder Reflections on Perinatal Depression Treatment PDF $40.00
$40.00
× Placeholder Delusional Infestation With Black Mold Presenting to the General Hospital PDF $40.00
$40.00
× Placeholder Effect of Reboxetine on Depression in Parkinson's Disease Patients PDF $40.00
$40.00
× Placeholder Sublingual Ketamine for Rapid Relief of Suicidal Ideation PDF $40.00
$40.00
× Placeholder The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals PDF $40.00
$40.00
× Placeholder Doxepin in the Treatment of Primary Insomnia: A Placebo-Controlled, Double-Blind, Polysomnographic Study PDF $40.00
$40.00
× Placeholder Once- Versus Twice-Daily Venlafaxine Therapy in Major Depression: A Randomized, Double-Blind Study PDF $40.00
$40.00
× Placeholder Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $440.00
Total $440.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe